Ranbaxy Laboratories Ltd has informed BSE that the Company has formulated its Medium Term Plan (MTP) for the period 2010-2012. As per the MTP, the Company aims to achieve global consolidated turnover of Three Billion US Dollars (approx. INR 140 billion) for the financial year ending December 2012.